论文部分内容阅读
目的观察分析依达拉奉联合七叶皂苷钠对脑出血的治疗作用。方法 100例脑出血患者,随机分为观察组和对照组,每组50例。对照组采用七叶皂苷钠治疗,观察组采用依达拉奉联合七叶皂苷钠治疗。观察并比较两组患者的神经功能缺损评分以及治疗总有效率。结果治疗后两组患者的神经功能缺损评分都明显下降,但观察组相较于对照组评分下降更明显(P<0.05);观察组治疗总有效率为94%,明显高于对照组的76%,差异具有统计学意义(P<0.05)。结论使用依达拉奉联合七叶皂苷钠治疗脑出血疗效显著,同时提高了患者的生活质量和恢复速度,值得进行临床推广运用。
Objective To observe the therapeutic effect of edaravone combined with sodium aescinate on cerebral hemorrhage. Methods 100 cases of cerebral hemorrhage were randomly divided into observation group and control group, 50 cases in each group. The control group was treated with sodium aescinate, while the observation group was treated with edaravone combined with sodium aescinate. Observe and compare the neurological deficit scores and the total effective rate in both groups. Results After treatment, the scores of neurological deficit in both groups were significantly decreased, but the scores of the observation group were significantly lower than those of the control group (P <0.05). The total effective rate of the observation group was 94%, which was significantly higher than that of the control group %, The difference was statistically significant (P <0.05). Conclusion The use of edaravone combined with sodium aescinate treatment of intracerebral hemorrhage significant effect, while improving patient quality of life and recovery rate, it is worth to carry out clinical application.